Medifast Inc (MED) 31.10 $MED
Medifast (MED) Michael C. MacDonald on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Mar 12, 8:31PM CDT
MED: 31.10 (+0.65)
After Hours Gainers / Losers
Seeking Alpha - at Seeking Alpha - Thu Mar 12, 4:37PM CDT
ZUMZ: 39.89 (+0.67), MED: 31.10 (+0.65), FTD: 30.37 (+0.74), LOCO: 27.00 (+1.11), PF: 39.86 (-0.35), ANAC: 54.24 (-1.88), FXCM: 2.10 (+0.04), ULTA: 152.02 (-0.27), ARO: 3.14 (+0.12), JMBA: 15.01 (+0.38)
Medifast misses by $0.08, misses on revenue
Seeking Alpha - at Seeking Alpha - Thu Mar 12, 3:20PM CDT
MED: 31.10 (+0.65)
Medifast, Inc. Announces Fourth Quarter and Fiscal Year 2014 Financial Results
PR Newswire - Thu Mar 12, 3:05PM CDT
Medifast, Inc. (NYSE: MED), a leading United States manufacturer and provider of clinically proven weight-loss and healthy living products and programs, today reported financial results for the fourth quarter and fiscal year ended December 31, 2014.
MED: 31.10 (+0.65)
Notable earnings after Thursday’s close
Seeking Alpha - at Seeking Alpha - Wed Mar 11, 4:35PM CDT
ZUMZ: 39.89 (+0.67), KRO: 12.80 (+0.26), TEAR: 2.58 (-0.01), HIL: 3.38 (+0.03), OMED: 28.00 (+0.92), PPHM: 1.49 (-0.04), FXCM: 2.10 (+0.04), ARO: 3.14 (+0.12), EGY: 3.08 (+0.05), RMAX: 32.61 (+0.37), IRET: 7.62 (+0.10), IRG: 5.28 (unch), MED: 31.10 (+0.65), KTOS: 5.82 (+0.10), FTD: 30.37 (+0.74), LOCO: 27.00 (+1.11), ANAC: 54.24 (-1.88), ULTA: 152.02 (-0.27), ATHX: 3.20 (+0.03), FF: 12.38 (-0.08), GST: 2.63 (+0.08), JMBA: 15.01 (+0.38)
Downgrade Alert for Medifast (MED)
Comtex SmarTrend(R) - Tue Mar 03, 7:11AM CST
Medifast (NYSE:MED) was downgraded from Neutral to Underperform at BofA/Merrill today. The stock closed yesterday at $32.35 on volume of 185,000 shares, above average daily volume of 76,000. Over the past year, Medifast has traded in a range of $24.76 to $36.06 and closed yesterday at $32.35, 31% above that low. In the last five trading sessions, the 50-day moving average (MA) has climbed 0.5% while the 200-day MA has risen 0.3%.
MED: 31.10 (+0.65)
Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Medifast, Inc. Stockholders
Business Wire - Mon Feb 02, 6:24PM CST
Kirby McInerney LLP is investigating potential claims against the Board of Directors of Medifast, Inc. ("Medifast" or the "Company"
(NYSE:MED) concerning the improper compensation of the Company's executives.
MED: 31.10 (+0.65)
Medifast Named SmartCEO Future 50 Award Winner for 4th Consecutive Year
PR Newswire - Wed Jan 21, 4:30PM CST
Medifast, Inc. (NYSE: MED), a leading United States manufacturer and provider of clinically proven, weight-loss and healthy living products and programs is proud to be recognized by SmartCEO magazine as a 2015 Future 50 Blue Chip company for the fourth consecutive year.
MED: 31.10 (+0.65)
Medifast Launches New "Your Whole World Gets Better" Advertising Campaign
PR Newswire - Thu Jan 08, 4:30PM CST
Medifast, Inc. (NYSE: MED), a leading United States manufacturer and provider of clinically proven weight-loss and healthy living products and programs, today announced the launch of its new advertising campaign, "Your Whole World Gets Better(TM)," which mixes Medifast weight-loss success stories with humorous active living vignettes to illustrate the positive impact achieving and maintaining a healthy weight can have on all aspects of your life.
MED: 31.10 (+0.65)
Be Careful Betting On More Upside At Medifast
George Hanley - at Seeking Alpha - Wed Jan 07, 5:10PM CST
MED: 31.10 (+0.65), WTW: 8.60 (-0.81)
Medifast's New Year’s Resolution: Increase Revenue and Profits
at The Street - Mon Jan 05, 4:50PM CST
Medifast will mix coaching and technology to achieve its 2015 goal of double-digit earnings growth, said CEO Michael MacDonald.
MED: 31.10 (+0.65)
New Information Reveals Opportunity in Volatility: New Reports on Lorillard, Mead Johnson, Medifast, Michael Kors, and Movado Group
PR Newswire - Wed Dec 31, 6:40AM CST
Moments ago, Analysts Review released new research updates concerning several important developing situations including Lorillard (NYSE: LO), Mead Johnson (NYSE: MJN), Medifast (NYSE: MED), Michael Kors (NYSE: KORS), and Movado Group (NYSE: MOV). Analysts Review provides a single unified platform for investors' to hear about what matters - proudly employing registered CFA® research staff and rigorous compliance procedures. The full research reports are being made available to the public for informational purposes only.
MJN: 102.28 (+2.08), MED: 31.10 (+0.65), LO: 67.34 (+0.38), KORS: 66.13 (-0.69), MOV: 24.10 (+0.11)
Medifast, Inc. to Participate in the 17th Annual ICR XChange Conference
PR Newswire - Tue Dec 30, 7:00AM CST
Medifast, Inc. (NYSE: MED), a leading United States manufacturer and provider of clinically proven, portion-controlled weight-loss products and programs, announced today that Michael C. MacDonald, Chairman and Chief Executive Officer, Meg Sheetz, President and Chief Operating Officer, and Timothy Robinson, Chief Financial Officer, will present at the 17th Annual ICR XChange Conference on Tuesday, January 13, 2015 in Orlando, FL.
MED: 31.10 (+0.65)
Medifast Board Member Barry B. Bondroff, CPA Becomes an NACD Fellow
PR Newswire - Thu Dec 18, 4:30PM CST
Medifast, Inc., (NYSE: MED), a leading United States manufacturer and provider of clinically proven weight-loss and healthy living products and programs, is proud to announce that Barry B. Bondroff, Lead Director on the Medifast Board of Directors, has become a National Association of Corporate Directors (NACD) Fellow, the highest level of credentialing for corporate directors and corporate governance professionals.
MED: 31.10 (+0.65)
Headaches For Medifast Investors
Duane Bair - at Seeking Alpha - Wed Dec 17, 8:18AM CST
MED: 31.10 (+0.65)
Medifast Launches New Energy Drops & Flavor Infusers(TM)
PR Newswire - Tue Dec 09, 4:30PM CST
Medifast, Inc. (NYSE: MED), a leading United States manufacturer and provider of clinically proven, weight-loss and healthy living products and programs, is proud to announce the launch of their newest Energy Drops and Flavor Infusers(TM).
MED: 31.10 (+0.65)
Medifast Implements Next Phase Of Weight Control Center Strategy
PR Newswire - Fri Dec 05, 4:30PM CST
Medifast, Inc. (NYSE: MED), a leading United States manufacturer and provider of clinically proven, weight-loss products and programs, announced today the plan by a subsidiary to close 34 corporate-owned Medifast Weight Control Centers by December 31, 2014. Medifast also expects its subsidiary to sell the assets of 17 corporate-owned Medifast Weight Control Centers to existing business partners, which would then be transitioned to the franchise model.
MED: 31.10 (+0.65)
Medifast's New Parking Spots Encourage Healthier Choices
PR Newswire - Wed Nov 26, 6:30AM CST
Medifast, Inc. (NYSE: MED), a leading United States manufacturer and provider of clinically proven, weight-loss and healthy living products and programs, announces the launch of its #BestSpot in the Lot health and wellness initiative. The #BestSpot fitness campaign will inspire the community to become more active by rethinking the common view that the closest parking spaces are the best.
MED: 31.10 (+0.65)
Campbell Cuts Fiscal '15 View Despite Strong Q1 Earnings - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 25, 4:25PM CST
Campbell Soup Company (CPB) has made an encouraging start to fiscal 2015, with better-than-expected first-quarter results.
HAIN: 64.44 (+0.88), CAG: 34.96 (+0.60), MED: 31.10 (+0.65), CPB: 45.75 (+0.45)
Medifast (MED) Michael C. MacDonald on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Mar 12, 8:31PM CDT
MED: 31.10 (+0.65)
After Hours Gainers / Losers
Seeking Alpha - at Seeking Alpha - Thu Mar 12, 4:37PM CDT
ZUMZ: 39.89 (+0.67), MED: 31.10 (+0.65), FTD: 30.37 (+0.74), LOCO: 27.00 (+1.11), PF: 39.86 (-0.35), ANAC: 54.24 (-1.88), FXCM: 2.10 (+0.04), ULTA: 152.02 (-0.27), ARO: 3.14 (+0.12), JMBA: 15.01 (+0.38)
Medifast misses by $0.08, misses on revenue
Seeking Alpha - at Seeking Alpha - Thu Mar 12, 3:20PM CDT
MED: 31.10 (+0.65)
Medifast, Inc. Announces Fourth Quarter and Fiscal Year 2014 Financial Results
PR Newswire - Thu Mar 12, 3:05PM CDT
Medifast, Inc. (NYSE: MED), a leading United States manufacturer and provider of clinically proven weight-loss and healthy living products and programs, today reported financial results for the fourth quarter and fiscal year ended December 31, 2014.
MED: 31.10 (+0.65)
Notable earnings after Thursday’s close
Seeking Alpha - at Seeking Alpha - Wed Mar 11, 4:35PM CDT
ZUMZ: 39.89 (+0.67), KRO: 12.80 (+0.26), TEAR: 2.58 (-0.01), HIL: 3.38 (+0.03), OMED: 28.00 (+0.92), PPHM: 1.49 (-0.04), FXCM: 2.10 (+0.04), ARO: 3.14 (+0.12), EGY: 3.08 (+0.05), RMAX: 32.61 (+0.37), IRET: 7.62 (+0.10), IRG: 5.28 (unch), MED: 31.10 (+0.65), KTOS: 5.82 (+0.10), FTD: 30.37 (+0.74), LOCO: 27.00 (+1.11), ANAC: 54.24 (-1.88), ULTA: 152.02 (-0.27), ATHX: 3.20 (+0.03), FF: 12.38 (-0.08), GST: 2.63 (+0.08), JMBA: 15.01 (+0.38)
Downgrade Alert for Medifast (MED)
Comtex SmarTrend(R) - Tue Mar 03, 7:11AM CST
Medifast (NYSE:MED) was downgraded from Neutral to Underperform at BofA/Merrill today. The stock closed yesterday at $32.35 on volume of 185,000 shares, above average daily volume of 76,000. Over the past year, Medifast has traded in a range of $24.76 to $36.06 and closed yesterday at $32.35, 31% above that low. In the last five trading sessions, the 50-day moving average (MA) has climbed 0.5% while the 200-day MA has risen 0.3%.
MED: 31.10 (+0.65)
Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Medifast, Inc. Stockholders
Business Wire - Mon Feb 02, 6:24PM CST
Kirby McInerney LLP is investigating potential claims against the Board of Directors of Medifast, Inc. ("Medifast" or the "Company"
(NYSE:MED) concerning the improper compensation of the Company's executives. MED: 31.10 (+0.65)
Medifast Named SmartCEO Future 50 Award Winner for 4th Consecutive Year
PR Newswire - Wed Jan 21, 4:30PM CST
Medifast, Inc. (NYSE: MED), a leading United States manufacturer and provider of clinically proven, weight-loss and healthy living products and programs is proud to be recognized by SmartCEO magazine as a 2015 Future 50 Blue Chip company for the fourth consecutive year.
MED: 31.10 (+0.65)
Medifast Launches New "Your Whole World Gets Better" Advertising Campaign
PR Newswire - Thu Jan 08, 4:30PM CST
Medifast, Inc. (NYSE: MED), a leading United States manufacturer and provider of clinically proven weight-loss and healthy living products and programs, today announced the launch of its new advertising campaign, "Your Whole World Gets Better(TM)," which mixes Medifast weight-loss success stories with humorous active living vignettes to illustrate the positive impact achieving and maintaining a healthy weight can have on all aspects of your life.
MED: 31.10 (+0.65)
Be Careful Betting On More Upside At Medifast
George Hanley - at Seeking Alpha - Wed Jan 07, 5:10PM CST
MED: 31.10 (+0.65), WTW: 8.60 (-0.81)
Medifast's New Year’s Resolution: Increase Revenue and Profits
at The Street - Mon Jan 05, 4:50PM CST
Medifast will mix coaching and technology to achieve its 2015 goal of double-digit earnings growth, said CEO Michael MacDonald.
MED: 31.10 (+0.65)
New Information Reveals Opportunity in Volatility: New Reports on Lorillard, Mead Johnson, Medifast, Michael Kors, and Movado Group
PR Newswire - Wed Dec 31, 6:40AM CST
Moments ago, Analysts Review released new research updates concerning several important developing situations including Lorillard (NYSE: LO), Mead Johnson (NYSE: MJN), Medifast (NYSE: MED), Michael Kors (NYSE: KORS), and Movado Group (NYSE: MOV). Analysts Review provides a single unified platform for investors' to hear about what matters - proudly employing registered CFA® research staff and rigorous compliance procedures. The full research reports are being made available to the public for informational purposes only.
MJN: 102.28 (+2.08), MED: 31.10 (+0.65), LO: 67.34 (+0.38), KORS: 66.13 (-0.69), MOV: 24.10 (+0.11)
Medifast, Inc. to Participate in the 17th Annual ICR XChange Conference
PR Newswire - Tue Dec 30, 7:00AM CST
Medifast, Inc. (NYSE: MED), a leading United States manufacturer and provider of clinically proven, portion-controlled weight-loss products and programs, announced today that Michael C. MacDonald, Chairman and Chief Executive Officer, Meg Sheetz, President and Chief Operating Officer, and Timothy Robinson, Chief Financial Officer, will present at the 17th Annual ICR XChange Conference on Tuesday, January 13, 2015 in Orlando, FL.
MED: 31.10 (+0.65)
Medifast Board Member Barry B. Bondroff, CPA Becomes an NACD Fellow
PR Newswire - Thu Dec 18, 4:30PM CST
Medifast, Inc., (NYSE: MED), a leading United States manufacturer and provider of clinically proven weight-loss and healthy living products and programs, is proud to announce that Barry B. Bondroff, Lead Director on the Medifast Board of Directors, has become a National Association of Corporate Directors (NACD) Fellow, the highest level of credentialing for corporate directors and corporate governance professionals.
MED: 31.10 (+0.65)
Headaches For Medifast Investors
Duane Bair - at Seeking Alpha - Wed Dec 17, 8:18AM CST
MED: 31.10 (+0.65)
Medifast Launches New Energy Drops & Flavor Infusers(TM)
PR Newswire - Tue Dec 09, 4:30PM CST
Medifast, Inc. (NYSE: MED), a leading United States manufacturer and provider of clinically proven, weight-loss and healthy living products and programs, is proud to announce the launch of their newest Energy Drops and Flavor Infusers(TM).
MED: 31.10 (+0.65)
Medifast Implements Next Phase Of Weight Control Center Strategy
PR Newswire - Fri Dec 05, 4:30PM CST
Medifast, Inc. (NYSE: MED), a leading United States manufacturer and provider of clinically proven, weight-loss products and programs, announced today the plan by a subsidiary to close 34 corporate-owned Medifast Weight Control Centers by December 31, 2014. Medifast also expects its subsidiary to sell the assets of 17 corporate-owned Medifast Weight Control Centers to existing business partners, which would then be transitioned to the franchise model.
MED: 31.10 (+0.65)
Medifast's New Parking Spots Encourage Healthier Choices
PR Newswire - Wed Nov 26, 6:30AM CST
Medifast, Inc. (NYSE: MED), a leading United States manufacturer and provider of clinically proven, weight-loss and healthy living products and programs, announces the launch of its #BestSpot in the Lot health and wellness initiative. The #BestSpot fitness campaign will inspire the community to become more active by rethinking the common view that the closest parking spaces are the best.
MED: 31.10 (+0.65)
Campbell Cuts Fiscal '15 View Despite Strong Q1 Earnings - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 25, 4:25PM CST
Campbell Soup Company (CPB) has made an encouraging start to fiscal 2015, with better-than-expected first-quarter results.
HAIN: 64.44 (+0.88), CAG: 34.96 (+0.60), MED: 31.10 (+0.65), CPB: 45.75 (+0.45)
